Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
biotech
national top stories
san francisco blog main
aldehyde
aldeyra therapeutics
allergic conjunctivitis
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biofourmis
biovotion
bluebird bio
chugai pharmaceutical
deals
drugs
dry eye disease
duchenne muscular dystrophy
dyne therapeutics
edbi
facioscapulohumeral muscular dystrophy
fda
gaido health
gene therapy
investing
joshua brumm
kaleido biosciences
kuldeep singh rajput
massmutual ventures
medical devices
muscular dystrophy
myotonic dystrophy type 1
new york blog main
novartis
What
data
3
×
therapeutics
3
×
drug
ago
aldeyra
analytics
biofourmis
biotechs
closer
considering
devices
digital
disclosed
diseases
dyne
early
employs
expected
experimental
eye
eyes
fda
fighting
filing
genetic
globally
hauls
having
help
humans
inflammation
ipo
ipos
long
medicine
medicines
million
multiple
muscle
new
Language
unset
Current search:
therapeutics
×
boston
×
data
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
